The activation state of mTORC1, a master regulator of cell growth, is particularly sensitive to changes in the intracellular levels of the amino acid arginine, but the sensing mechanisms are poorly understood. In this issue of Cell, Chantranupong et al. identify CASTOR1 as a direct arginine sensor that acts through the GATOR2 complex to regulate mTORC1.
The mechanistic target of rapamycin complex 1 (mTORC1) is a highly conserved effector of cellular growth signals with the capacity to integrate diverse cues from intracellular nutrients and exogenous growth factors and hormones. Pro-growth signals stimulate the protein kinase activity of mTORC1, and it regulates downstream processes to promote an acute switch from catabolic (e.g., autophagy) to anabolic (e.g., protein, lipid, and nucleotide synthesis) metabolism (Dibble and Manning, 2013) . Given the high cost of this metabolic shift, in the form of cellular energy, reducing equivalents and nutrients required, it is not surprising that mTORC1 is under tight regulatory control by a complex network of growth factor signaling and nutrient sensing pathways. This upstream network is dysregulated in a diverse array of human diseases, including cancer, metabolic diseases, neurological disorders, and autoimmune diseases. As such, there has been intense interest in defining the key mechanisms by which mTORC1 senses changes in cellular growth conditions. In this issue of Cell, Chantranupong et al. (2016) report the identification and characterization of a new direct sensor of arginine required for the responsiveness of mTORC1 to this conditionally essential amino acid.
A breakthrough in understanding how mTORC1 integrates diverse growth signals came from the recognition that its activation occurs through the coordinated action of two sets of small GTPases, the Rag and Rheb proteins, on the cytosolic face of the lysosome. The presence of sufficient intracellular amino acids promotes mTORC1 translocation to the lysosomal surface through its interaction with a heterodimeric complex of two members of the Rag family of GTPases (RagA or B with RagC or D), which are bound to the lysosome through interactions with a protein complex dubbed the Ragulator (Bar-Peled and Sabatini, 2014 The molecular function of GATOR2 is unknown but genetic epistasis analyses suggest that it could be an upstream inhibitor of GATOR1. The collective action of the Rag proteins and these regulatory complexes promote mTORC1 activation by amino acids. However, translocation of mTORC1 to the lysosome alone is not sufficient for its activation (Bar-Peled and Sabatini, 2014). Full mTORC1 activation requires signals from exogenous growth factors. Amino acid-dependent recruitment of mTORC1 to the lysosome brings it into close proximity with the small GTPase Rheb. In the GTP-bound state, Rheb is a potent and essential activator of mTORC1. Growth factor signaling through the PI3K-Akt pathway promotes accumulation of Rheb GTP at the lysosome by directly stimulating release of a Rheb-GAP complex comprised of the tuberous sclerosis complex (TSC) tumor suppressors (Menon et al., 2014) . Maximal activation of mTORC1, therefore, requires input from both amino acid and growth factor signaling pathways, and it is at the lysosomal surface where these signals are integrated (Figure 1) .
How distinct intracellular amino acids are sensed and relayed to the Rag proteins to influence the activation state of mTORC1 is just coming to light. It is well established that distinct exogenous signals are sensed by growth factor-specific cell surface receptors and relayed to shared downstream signaling pathways, such as the PI3K-Akt-TSC pathway, to activate mTORC1. However, it is unclear whether all amino acids, or only a subset, are directly monitored in cells or if their levels are indirectly inferred through secondary effects on metabolites or protein synthesis. Although it remains possible that a global sensor of amino acid levels operates, earlier observations found that mTOR activation is particularly sensitive to the levels of leucine and arginine (Hara et al., 1998) , suggesting that specific amino acid sensors might exist. Indeed, Sestrin1 and 2 were recently identified as cytosolic leucine sensors that bind leucine directly at physiological intracellular concentrations (Wolfson et al., 2016) . Under leucine-depleted conditions, the Sestrins physically associate with and inhibit GATOR2. Upon leucine ) recruits mTORC1 to the lysosomal surface through interactions between the Rag proteins and the Ragulator, a complex of proteins in close association with the V-ATPase. The GTP/ GDP-binding status of the Rag proteins is regulated in response to amino acids by the action of two GAP complexes: GATOR1, which acts as a GAP for RagA/B and Folliculin, which acts as a GAP for RagC/D. In the presence of amino acids, Folliculin is on and GATOR1 is off, thereby promoting accumulation of the RagA/B GTP -RagC/D GDP heterodimers active for mTORC1 recruitment. Amino acid sensing appears to take place in both the lysosomal lumen, through the arginine transporter SLC38A9, and the cytosol, through proteins that bind to and inhibit GATOR2. These GATOR2-binding amino acid sensors include the Sestrins, which bind directly to cytosolic leucine, and CASTOR1 dimers, which bind directly to cytosolic arginine. In both cases, amino acid binding releases these proteins from GATOR2. The molecular function of GATOR2 is unknown, but it promotes mTORC1 activation by amino acids, perhaps through inhibition of GATOR1. The translocation of mTORC1 to the lysosome in response to amino acids brings it in proximity to Rheb, which is essential for mTORC1 activation. (B) Amino acid depletion impairs mTORC1 translocation to the lysosome, resulting in its inability to be activated by Rheb. In the absence of leucine or arginine, respectively, the Sestrins or CASTOR1 dimers bind to and inhibit GATOR2. Activated GATOR1 together with the loss of Folliculin and SLC38A9 activity leads to conversion of the Rag GTPases into the RagA/B GDP -RagC/D GTP state incapable of binding to mTORC1. Note: Positive regulators of mTORC1 are depicted in blue, negative regulators are depicted in red.
binding, the Sestrins are released from GATOR2, allowing it to promote mTORC1 activation through the Rag GTPases. The lysosomal amino acid transporter SLC38A9 was recently identified as a candidate arginine sensor that binds directly to the Ragulator and Rags and is required for mTORC1 activation by arginine (Rebsamen et al., 2015; Wang et al., 2015) . Chantranupong et al. (2016) now identify cellular arginine sensor for mTORC1 (CASTOR1, previously named GATSL3) that directly binds to physiological concentrations of cytosolic arginine through conserved ACT domains. Homodimers of CASTOR1, or CASTOR1 heterodimers with CASTOR2 (previously named GATSL2), a protein with 63% identity to CASTOR1 that lacks the capacity to bind to arginine, bind to and regulate GATOR2 through a mechanism highly analogous to leucine sensing by Sestrin2. Under arginine-replete conditions, arginine binding by CASTOR1 prevents its inhibitory interaction with GATOR2, thereby promoting mTORC1 activation ( Figure 1A ). Arginine depletion triggers binding of CASTOR1 to GATOR2, resulting in an inhibition of mTORC1 ( Figure 1B) .
The CASTOR1-dependent mechanism of amino acid sensing by the mTORC1 pathway is highly specific for arginine. Importantly, the CASTOR dimers appear to bind to GATOR2 at distinct sites from the Sestrins allowing for non-redundant and independent regulation of this complex by arginine and leucine, respectively. The inability of CASTOR2, which can also form homodimers, to bind to arginine is analogous to Sestrin3, which does not bind leucine but can still bind to and inhibit GATOR2. Therefore, the abundance of Sestrin1 and 2 relative to Sestrin 3 and of CASTOR1 relative to CASTOR2 is likely to tune cellular sensitivity to leucine and arginine, and could provide a molecular explanation for observed differences in leucine and arginine sensitivities between distinct cell and tissue types.
While identification of the Sestrins and CASTOR1 as direct sensors of specific amino acids that regulate mTORC1 are key breakthroughs in this field, several important questions remain. GATOR2 has now emerged as a key integrator of cellular amino acid availability, but its molecular function and role in promoting mTORC1 signaling remains elusive. How signals from cytosolic arginine levels, sensed by CASTOR1 and intra-lysosomal arginine levels, likely sensed through SLC38A9 (Wang et al., 2015) , converge to regulate mTORC1's activation by Rheb at the lysosomal surface is also unclear. Importantly, arginine starvation and refeeding, alone, strongly affects the regulation of mTORC1 signaling, yet does not appear to exert acute effects on its subcellular localization (Carroll et al., 2016) . Although the molecular mechanism is undefined, complete starvation of arginine, as well as total amino acids, has been suggested to promote localization of the TSC complex to lysosomal Rheb (Carroll et al., 2016; Demetriades et al., 2014) , thereby preventing its activation of mTORC1 in a manner analogous to growth factor withdrawal (Menon et al., 2014) . It is currently unclear how these observations fit with the emerging model of mTORC1 regulation by amino acids through the Rag proteins and the need for independent regulation of Rheb in order to properly integrate signals from intracellular nutrients and exogenous growth factors, which are well established to exert a hierarchy of regulation on mTORC1 (Dibble and Manning, 2013; Bar-Peled and Sabatini, 2014) .
It is worth noting that the molecular mechanisms underlying mTORC1 regulation discussed here have all been elucidated in just the past 8 years. The exquisite complexity of the signaling network being unraveled upstream of mTORC1 underscores the importance of the strict regulation of its downstream processes, which involve major shifts in cellular and systemic metabolism to control biomass production and storage. These upstream nodes of regulation are also those that are commonly perturbed in a diverse set of human diseases associated with aberrant mTORC1 activation. It will be interesting to see, through future studies, whether the CASTOR isoforms are found to be defective or dysregulated in these disease settings.
